Biolevate Closes €6M Seed Funding to Transform Drug Discovery and Personalized Medicine with AI November 30, 2024
Phare Bio Awarded Up To $27M from ARPA-H to Accelerate AI-Powered Drug Discovery and Develop Critically Needed New Classes of Antibiotics October 1, 2024
Insilico Medicine Reports Positive Phase IIa Results For a First-in-Class Drug Treatment For Idiopathic Pulmonary Fibrosis Designed by Generative AI September 26, 2024
RevolKa Announces the Closing of a $1.7M Series A Extension Funding to Accelerate Drug-Discovery Programs August 30, 2024
Study Shows AI-Powered Drug Discovery Has Near Perfect Success Rate in Phase I Clinical Trials June 12, 2024
AI to Independently Design Novel Drugs Soon: Eli Lilly Scientists Amazed by AI-Generated Molecules in Drug Discovery May 6, 2024
The Novo Nordisk Foundation Launches ‘Challenge Programme 2025 – The NNF Grand AI Challenge’ April 10, 2024
AION Labs Welcomes Amiti as Strategic Partner to Accelerate Israel’s Position as a Leading Hub for Transformative AI-Powered Drug Discovery Innovation January 14, 2024
Biolevate Closes €6M Seed Funding to Transform Drug Discovery and Personalized Medicine with AI November 30, 2024
Phare Bio Awarded Up To $27M from ARPA-H to Accelerate AI-Powered Drug Discovery and Develop Critically Needed New Classes of Antibiotics October 1, 2024
Insilico Medicine Reports Positive Phase IIa Results For a First-in-Class Drug Treatment For Idiopathic Pulmonary Fibrosis Designed by Generative AI September 26, 2024
RevolKa Announces the Closing of a $1.7M Series A Extension Funding to Accelerate Drug-Discovery Programs August 30, 2024
Study Shows AI-Powered Drug Discovery Has Near Perfect Success Rate in Phase I Clinical Trials June 12, 2024
AI to Independently Design Novel Drugs Soon: Eli Lilly Scientists Amazed by AI-Generated Molecules in Drug Discovery May 6, 2024
The Novo Nordisk Foundation Launches ‘Challenge Programme 2025 – The NNF Grand AI Challenge’ April 10, 2024
AION Labs Welcomes Amiti as Strategic Partner to Accelerate Israel’s Position as a Leading Hub for Transformative AI-Powered Drug Discovery Innovation January 14, 2024
